6 unknown. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Unknown 6 |
Follow Mucosal Melanoma: new trials by email Literature Review of Mucosal Melanoma trials Research Report on Mucosal Melanoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma Toripalimab, chemotherapy in combination with Endostar - Mucosal Melanoma | Phase 2 | Unknown | Fudan University | 31 | 2020-06-20 | 2020-07-15 |
| Postoperative Adjuvant Treatment of Completely Resected Mucosal Melanoma Phase II Study Toripalimab, Temozolomide - Mucosal Melanoma | Phase 2 | Unknown | Peking University Cancer Hospital & Institute | 294 | 2020-05-30 | 2022-01-25 |
| Toripalimab in Combination With Axitinib in Patients With Localized Mucosal Melanoma TORIPALIMAB INJECTION(JS001 ) Axitinib tablet (Inlyta®) - Mucosal Melanoma | Phase 2 | Unknown | Peking University Cancer Hospital & Institute | 30 | 2019-08-06 | 2022-01-31 |
| Apatinib Plus SHR1210 in Advanced Mucosal Melanoma apatinib plus SHR-1210 - Mucosal Melanoma, Advanced Cancer | Phase 2 | Unknown | Henan Cancer Hospital | 40 | 2019-06-04 | 2019-06-14 |
| Study of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma. CM082 plus JS001 - Mucosal Melanoma | Phase 2 | Unknown | AnewPharma | 40 | 2018-07-31 | 2019-07-05 |
| Mucosal Melanoma of Head and Neck in Intensity-modulated Radiotherapy Era RT - Mucosal Melanoma | Phase 2 | Unknown | Sun Yat-sen University | 30 | 2010-07-01 | 2018-01-30 |
toripalimab (2) · Axitinib (1) · Drug Therapy (1) · Temozolomide (1) · apatinib (1) · camrelizumab (1) · endostar protein (1) · vorolanib (1)
Peking University Cancer Hospital & Institute (2) · AnewPharma (1) · Fudan University (1) · Henan Cancer Hospital (1) · Sun Yat-sen University (1)
China (6)
Jing Ding, Master (1) · Jun Guo, M.D (1) · LiXia Lu, M.D. (1)